Indications: Type 2 diabetes, CV risk reduction in T2D patients with heart disease Doses: 0.6 mg (starter) 1.2 mg 1.8 mg/day Best for: Patients wanting a daily injectable with strong CV data Rybelsus (Oral Semaglutide Tablet) Rybelsus is the only oral GLP-1 medication currently available
Used thoughtfully, nootropic peptides may offer a middle ground between doing nothing and depending only on medications that were never designed with cognitive performance in mind
The review is happening at a time when Americans are turning to peptides at an unprecedented rate, driven by grifters in the online wellness space, who push these products for a profit without any clinical evidence they are either safe or effective
Bariatric surgery for obesity and metabolic conditions in adults
Foundayo pricing for LifeMD patients starts at a self-pay cost of US$149 per month for the initial dosage, with eligible commercially insured patients potentially paying as little as US$25 per month through a Lilly savings card and Medicare coverage anticipated from July 2026
The Challenge of Bioavailability What is Kojic Acid
